Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1Phase 1 1

Status

Completed 2Terminated 1Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 18Tumor-Agnostic 11Thoracic 5Sarcoma 5Gynecologic 4Breast 4Genitourinary 3CNS 3Lymphoid 2Dermatologic 2Other hematologic neoplasm 1Head & Neck 1

Conditions

Breast Neoplasms 117Triple Negative Breast Neoplasms 45Neoplasm Metastasis 11Pancreatic Neoplasms 8Inflammatory Breast Neoplasms 7Breast Neoplasms, Male 7Parkinson Disease 4, Autosomal Dominant Lewy Body 6Ovarian Neoplasms 6Carcinoma, Non-Small-Cell Lung 5Stomach Neoplasms 4Neoplasms 4Lung Neoplasms 4Carcinoma, Ductal, Breast 4Sarcoma 3Prostatic Neoplasms 3Lymphoma, Non-Hodgkin 3Endometrial Neoplasms 3Carcinoma, Renal Cell 3Carcinoma, Hepatocellular 3Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Small Cell Lung Carcinoma 2Hodgkin Disease 2Esophageal Neoplasms 2Carcinoma, Ovarian Epithelial 2Advanced Breast Cancer 2Thrombocytosis 1Stages II-III Breast Cancer 1Primary Myelofibrosis 1

Interventions

Paclitaxel 26pembrolizumab 24Docetaxel 20Capecitabine 19Fulvestrant 17Trastuzumab 16Anastrozole 15Cyclophosphamide 14Lapatinib 13Letrozole 11Carboplatin 11Radiotherapy 10Doxorubicin 10palbociclib 9Therapeutics 9Nivolumab 9Exercise 9Gemcitabine 8Cisplatin 8Blood Specimen Collection 8Tamoxifen 7Bevacizumab 7liposomal doxorubicin 6exemestane 6abemaciclib 6Vinorelbine 6Standard of Care 6Fluorouracil 6atezolizumab 5Surveys and Questionnaires 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Neoplasms × Albumin-Bound Paclitaxel × Breast × Clear all
NCT03678883 2026-04-03

9-ING-41 in Patients With Advanced Cancers

Actuate Therapeutics Inc.

Phase 2 Active not recruiting
350 enrolled
BreastCNSGastrointestinalGenitourinaryLymphoidOther hematologic neoplasmSarcomaThoracic

Bone Neoplasms, Breast Neoplasms, Glioma, Kidney Neoplasms, Lung Neoplasms, Lymphoma, Non-Hodgkin, Neoplasm Metastasis, Neoplasms, Hereditary Sensory and Autonomic Neuropathies, Pancreatic Neoplasms, Sarcoma, Colorectal Neoplasms, Leukemia-Lymphoma, Adult T-Cell

NCT01822314 2024-03-07

ETNA

Fondazione Michelangelo

Phase 3 Completed
632 enrolled
Breast

Breast Neoplasms, Neoplasms

NCT02280252 2020-11-23

Study of Concurrent Paclitaxel and Radiation: Correlation of Tumor Profiles With Pathologic Response

NYU Langone Health

Phase 2 Completed
69 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis, Neoplasms

NCT02476955 2020-09-30

Open-label Phase 1b Study of ARQ 092 in Combination With Anastrozole

ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)

Phase 1 Terminated
41 enrolled
BreastGynecologic

Uterine Cervical Neoplasms, Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡